Given their role in immune surveillance, NK cells are a target for various therapeutic strategies. Approaches include enhancing their cytotoxic activity using cytokines like IL-2 and IL-15, as well as using monoclonal antibodies to block inhibitory receptors. Additionally, adoptive transfer of ex vivo-expanded NK cells is being explored as a treatment for certain cancers and viral infections.